Nervous, endocrine, immune systems as a target for complementary and alternative medicine.

PubWeight™: 0.92‹?›

🔗 View Article (PMID 15584388)

Published in Adv Exp Med Biol on January 01, 2004

Authors

Shinji Kasahara1, Edwin L Cooper

Author Affiliations

1: Laboratory of Comparative Neuroimmunology, Department of Neurobiology, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, Box 951763, Los Angeles, California 90095-1763, USA. shinkoro@u.washington.edu

Articles citing this

Bioprospecting: a CAM Frontier. Evid Based Complement Alternat Med (2005) 1.82

Insights into the innate immunity of the Mediterranean mussel Mytilus galloprovincialis. BMC Genomics (2011) 1.05

Immunomodulation of Autoimmune Arthritis by Herbal CAM. Evid Based Complement Alternat Med (2010) 0.90

Articles by these authors

CAM, eCAM, Bioprospecting: The 21st Century Pyramid. Evid Based Complement Alternat Med (2005) 2.68

Drug Discovery, CAM and Natural Products. Evid Based Complement Alternat Med (2004) 2.64

Bioprospecting: a CAM Frontier. Evid Based Complement Alternat Med (2005) 1.82

Quercetin and cancer chemoprevention. Evid Based Complement Alternat Med (2011) 1.49

The danger theory: 20 years later. Front Immunol (2012) 1.38

Characterization of cells with different mitochondrial membrane potential during apoptosis. Cytometry A (2005) 1.35

Commentary on Traditional and Modern Biomedical Prospecting: Part II-The Benefits by Werner E.G. Muller, Heinz C. Schroder, Matthias Wiens, Sanja Perovic-Ottstadt, Renato Batel and Isabel M. Muller: Anti-protozoa and antiviral activities of non-cytotoxic truncated and variant analogues of mussel defensin by P. Roch, A. Beschin and E. Bernard. Evid Based Complement Alternat Med (2004) 1.14

Essential requirement of reduced glutathione (GSH) for the anti-oxidant effect of the flavonoid quercetin. Free Radic Res (2005) 1.07

Regional Strength in CAM. Evid Based Complement Alternat Med (2006) 1.04

Sex-specific effects of carotenoid intake on the immunological response to allografts in guppies (Poecilia reticulata). Proc Biol Sci (2004) 1.00

ECAM is waiting for eCAM. Evid Based Complement Alternat Med (2005) 0.91

Hypothetical mode of action of earthworm extract with hepatoprotective and antioxidant properties. J Zhejiang Univ Sci B (2008) 0.89

eCAM: On To Year 4. Evid Based Complement Alternat Med (2006) 0.87

Quercetin inhibits lymphocyte activation and proliferation without inducing apoptosis in peripheral mononuclear cells. Leuk Res (2008) 0.87

Toll-like receptor genes (TLRs) from Capitella capitata and Helobdella robusta (Annelida). Dev Comp Immunol (2007) 0.86

Is there room for paradox in CAM? Evid Based Complement Alternat Med (2007) 0.86

Stem cells and CAM. Evid Based Complement Alternat Med (2006) 0.85

Evaluation of an innate immune reaction to parasites in earthworms. J Invertebr Pathol (2004) 0.84

Leech responses to tissue transplantation. Tissue Cell (2003) 0.82

Monoclonal antibodies identify four distinct annelid leukocyte markers. Dev Comp Immunol (2004) 0.80

Heat shock protein and gliadin peptide promote development of peptidase antibodies in children with autism and patients with autoimmune disease. Clin Diagn Lab Immunol (2004) 0.80

Mass spectrometric analyses of CL(39), CL(41) and H(1), H(2), H(3) confirm identity with fetidin and lysenin produced by earthworm leukocytes. Dev Comp Immunol (2003) 0.79

eCAM: Darwin and Metchnikoff. Evid Based Complement Alternat Med (2009) 0.78

eCAM: moving forward. Evid Based Complement Alternat Med (2007) 0.78

Leeches: immune response, angiogenesis and biomedical applications. Curr Pharm Des (2003) 0.78

eCAM: Clinical Analyses and Increasing Visibility. Evid Based Complement Alternat Med (2009) 0.77

Immune systems, geographic information systems (GIS), environment and health impacts. J Toxicol Environ Health B Crit Rev (2004) 0.77

Coelomocyte locomotion in the sipunculan Themiste petricola induced by exogenous and endogenous chemoattractants: role of a CD44-like antigen--HA interaction. J Invertebr Pathol (2002) 0.77

eCAM benefits from diversity that derives from CAM. Evid Based Complement Alternat Med (2005) 0.77

Earthworm leukocytes react with different mammalian antigen-specific monoclonal antibodies. Zoology (Jena) (2002) 0.77

Colony collapse disorder may affect complementary and alternative medicine. Evid Based Complement Alternat Med (2007) 0.75

Identification of diseases that may be targets for complementary and alternative medicine (CAM). Adv Exp Med Biol (2004) 0.75

Pomegranate: its health and biomedical potential. Evid Based Complement Alternat Med (2013) 0.75

Medical ethnobiology and ethnopharmacology in latin america. Evid Based Complement Alternat Med (2012) 0.75

Neuroendocrine mechanisms of acupuncture. Evid Based Complement Alternat Med (2012) 0.75

Marine biotechnology. Evid Based Complement Alternat Med (2011) 0.75

Brian Solomon. Dev Comp Immunol (2015) 0.75